| 英文名称 | 中文名称 | CAS | MF |
|
(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl-4-(N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-d9-sulfamoyl)phenylcarbamate(Darunavir-d9 Impurity)
|
|
|
C27H37N3O7S
|
|
[(1R,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDRO-1-PHENANTHRENYL]-N-[4-(BENZYLOXY)BENZYL]METHANAMINE
|
|
|
C34H43NO
|
|
[(1R,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDRO-1-PHENANTHRENYL]-N-(2-METHOXYBENZYL)METHANAMINE HYDROCHLORIDE
|
|
|
C28H40ClNO
|
|
[(1R,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDRO-1-PHENANTHRENYL]-N-(4-FLUOROBENZYL)METHANAMINE HYDROCHLORIDE
|
|
|
C27H37ClFN
|
|
2-[({[(1R,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDRO-1-PHENANTHRENYL]METHYL}AMINO)METHYL]-6-METHOXYPHENOL
|
|
|
C28H39NO2
|
|
(1R,3aS,5aR,5bR,7aR,9R,11aR,11bR,13bR)-9-Hydroxy-1
|
|
|
|
|
(1R,3AS,5AR,5BR,7AR,9R,11AR,11BR,13BR)-9-HYDROXY-1-ISOPROPENYL-5A,5B,8,8,11A-PENTAMETHYL-ICOSAHYDRO-CYCLOPENTA[A]CHRYSENE-3A-CARBOXYLIC ACID
|
|
|
C30H48O3
|
|
4-[({[(1R,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDRO-1-PHENANTHRENYL]METHYL}AMINO)METHYL]-1,2-BENZENEDIOL
|
|
|
C27H37NO2
|
|
[(1R,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDRO-1-PHENANTHRENYL]-N-(1-PYRENYLMETHYL)METHANAMINE
|
|
|
C37H41N
|
|
[(1R,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDRO-1-PHENANTHRENYL]-N-(4-METHOXY-2,5-DIMETHYLBENZYL)METHANAMINE HYDROCHLORIDE
|
|
|
C30H44ClNO
|
|
[3R,3aS,6aS]-3-[[(R)-Tetrahydrofuran]-2-yl]dihydro-1-benzyl-1H,3H-furo[3,4-c]isoxazol-6(6aH)-one
|
|
|
|
|
(4R,4aS,8aS)-8a-Hydroxy-1-methylene-4-(phenylsulfonyl)decahydronaphthalene
|
|
|
|
|
(3R,4aS,9aS)-3-[[(1R)-1-(3-Furyl)-6,7-dihydro-3β-hydroxy-1H,3H-3aα,7aα-methanoisobenzofuran-4-yl]methyl]-3,4,4a,9a-tetrahydro-3-hydroxy-5,5,9a-trimethyl-1,2-dioxino[4,3-c]oxepin-7(5H)-one
|
|
73703-76-1
|
|
|
[3R,3aS,6aS]-3-[(R)-1,4-Dioxaspiro[4.5]decan-2-yl]dihydro-1-benzyl-1H,3H-furo[3,4-c]isoxazol-6(6aH)-one
|
|
|
|
|
[3R,3aS,6aS]-3-[(S)-1-(Phenylmethoxy)ethyl]dihydro-1-benzyl-1H,3H-furo[3,4-c]isoxazol-6(6aH)-one
|
|
|
|
|
[3R,3aS,6aS]-3-[[(S)-Tetrahydrofuran]-2-yl]dihydro-1-benzyl-1H,3H-furo[3,4-c]isoxazol-6(6aH)-one
|
|
|
|
|
(R)-1-[(3aS,4aS,6aα,10bα)-Tetradecahydro-10β-hydroxy-3a,8,10aβ-trimethylcyclopropa[j]phenanthren-8β-yl]-1,2-ethanediol
|
|
7141-92-6
|
|
|
(2R,4AS,6AS,6BR,8AR,12AR,12BR)-10-HYDROXY-1,2,6A,6B,9,9,12A-HEPTAMETHYL-1,3,4,5,6,6A,6B,7,8,8A,9,10,11,12,12A,12B,13,14B-OCTADECAHYDRO-2H-PICENE-4A-CARBOXYLIC ACID
|
|
|
C30H48O3
|
|
(2R,3AS,7AS)-OCTAHYDRO-INDOLE-2-CARBOXYLIC ACID
|
|
|
C9H15NO2
|
|
(4R,4AS,8AS)-4-(4-METHOXYPHENYL)OCTAHYDRO-2H-PYRANO[2,3-D]PYRIMIDIN-2-ONE
|
|
|
C14H18N2O3
|
|
(1R,4aS,10aS)-6,7-diacetyl-1,4a-dimethyl-9-oxo-3,4,10,10a-tetrahydro-2 H-phenanthrene-1-carbonitrile
|
|
5344-93-4
|
C21H23NO3
|
|
(2R,6AS,12AS)-2-ISOPROPENYL-8,9-DIMETHOXY-1,2,12,12A-TETRAHYDRO-6AH-CHROMENO[3,4-B]FURO[2,3-H]CHROMEN-6-ONE
|
|
|
C23H22O6
|
|
(4R,4AS,8AS)-4-PHENYLOCTAHYDRO-2H-PYRANO[2,3-D]PYRIMIDIN-2-ONE
|
|
|
C13H16N2O2
|
|
(6R,8aS)-1,2,8,8a-Tetrahydro-6-phenyl-3H,6H-7-oxa-3a,5-diazaazulen-4(5H)-one
|
|
|
|
|
(2R,2aS)-2a,3,4,5-Tetrahydro-6,7-diacetoxy-2,2a-[[[(1S,4R)-1,2,3,4-tetrahydro-4-isopropenyl-1,6-dimethylnaphthalene]-8,7-diyl]dioxy]-2,5α,8-trimethylacenaphthene
|
|
|
|
|
(2R,2aS)-2a,3,4,5-Tetrahydro-6,7-diacetoxy-2,2a-[[[(1S,4S)-1,2,3,4-tetrahydro-4-isopropenyl-1,6-dimethylnaphthalene]-8,7-diyl]dioxy]-2,5α,8-trimethylacenaphthene
|
|
|
|
|
(6R,8aS)-1,2,8,8a-Tetrahydro-6-(2-methoxyphenyl)-3H,6H-7-oxa-3a,5-diazaazulen-4(5H)-one
|
|
|
|
|
(7R,13aS)-5,8,13,13a-Tetrahydro-2,9-dihydroxy-3,10-dimethoxy-7-methyl-6H-dibenzo[a,g]quinolizinium
|
|
63527-13-9
|
|
|
(1R,14aS)-3,3aα,4,5-Tetrahydro-8-hydroxy-1-[(Z)-4-hydroxy-3-methyl-2-butenyl]-3,3,11,11-tetramethyl-13-(3-methyl-2-butenyl)-1,5β-methano-7H,11H-furo[3,4-g]pyrano[3,2-b]xanthene-7,15-dione
|
|
55452-65-8
|
|
|
(6R,8aS)-1,2,8,8a-Tetrahydro-6-(1-naphtyl)-3H,6H-7-oxa-3a,5-diazaazulen-4(5H)-one
|
|
|
|
|
(R)-Bicalutamide
|
(R)-比卡鲁胺
|
113299-40-4
|
C18H14F4N2O4S
|
|
(+)-(2R,8AS)-(CAMPHORSULFONYL)OXAZIRIDINE
|
|
|
C11H17NO4S
|
|
(R)-Bicalutamide (1S)-Camphanic Acid Ester
|
|
1217546-57-0
|
C28H26F4N2O7S
|
|
Ras(31-43)Blocking Pep
|
|
|
|
|
(R)-Armentomycin
|
|
|
|
|
6R 12-AR-METHYL-1,2,3,4-TETRA HYDRO-2-CHLOROMETHYL-1-
|
|
|
|
|
（6R,12AR）-METHYL-1,2,3,4-TETRAHYDRO-2-CHLOROETHYL-1-(3,4-METHYLENEDIOXYPHENYL)-9H-PYRIDO-[3,4-B]-INDOLE-3-CARBOXYLATE
|
|
|
|
|
(1R,5AS,5BR,11AS)-9-(HYDROXYIMINO)-1-ISOPROPENYLICOSAHYDRO-3AH-CYCLOPENTA[A]CHRYSENE-3A-CARBOXYLIC ACID
|
|
|
C25H37NO3
|
|
(6R,6aS,12bR)-6,6a,8,12b-Tetrahydro-6α-(3,4,5-trimethoxyphenyl)-3,10,11,12-tetramethoxy[2]benzopyrano[3,4-c][1]benzopyran-8-one
|
|
|
|
|
(6R,6aS,12bR)-6,6a,8,12b-Tetrahydro-6α-(3,4-dihydroxyphenyl)-3,10,11,12-tetrahydroxy[2]benzopyrano[3,4-c][1]benzopyran-8-one
|
|
|
|
|
(6R,6aS,12bR)-6,6a,8,12b-Tetrahydro-6α-(3,4-dimethoxyphenyl)-3,10,11,12-tetramethoxy[2]benzopyrano[3,4-c][1]benzopyran-8-one
|
|
|
|
|
[3R,8aS]-3α-(2-Bromophenyl)octahydroindolizine
|
|
|
|
|
(6R,6aS,12bR)-6,6a,8,12b-Tetrahydro-6α-(3,4,5-trihydroxyphenyl)-3,10,11,12-tetrahydroxy[2]benzopyrano[3,4-c][1]benzopyran-8-one
|
|
|
|
|
RASCHING RALOX LC
|
|
|
|
|
(1R,4aS,4bR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,9,10,10a-octahydro phenanthrene-1-carboxylic acid
|
|
79-54-9
|
C20H30O2
|
|
(4R,4aS,6bR,8aS,12bS,14aS)-8a-Hydroxymethyl-4,4a,6b,11,11,12b,14a-heptamethyl-icosahydro-picen-3-one
|
|
|
C30H50O2
|
|
Raschig rings
|
|
|
|
|
(4R,4AS,6BR,8AR,12BS,14AS)-4,4A,6B,8A,11,11,12B,14 A-OCTAMETHYL-ICOSAHYDRO-PICEN-3-ONE
|
|
|
C30H50O
|
|
(1R,5AS,5BR,11AS)-1-ISOPROPENYL-9-OXOICOSAHYDRO-3AH-CYCLOPENTA[A]CHRYSENE-3A-CARBALDEHYDE
|
|
|
C25H36O2
|
|
(1R,5AS,5BR,11AS)-3A-FORMYL-1-ISOPROPENYLICOSAHYDRO-1H-CYCLOPENTA[A]CHRYSEN-9-YL ACETATE
|
|
|
C27H40O3
|
|
(4R,4aS,6bR,8aS,12bS,14aS)-8a-Hydroxymethyl-4,4a,6
|
|
|
|
|
(4R,4aS,6bR,8aR,12bS,14aS)-4,4a,6b,8a,11,11,12b,14
|
|
|
|
|
(4R,4AS,6BR,8AS,12BS,14AS)-8A-HYDROXYMETHYL-4,4A,6 B,11,11,12B,14A-HEPTAMETHYL-ICOSAHYDRO-PICEN-3-ONE
|
|
|
C30H50O2
|
|
R(-)-(4AS,10BS)-3,4,4A,10B-TETRAHYDRO-4-PROPYL-2H,5H-[1]BENZOPYRANO-[4,3-B]-1,4-OXAZIN-9-OL HYDROCHLORIDE
|
|
|
C14H20ClNO3
|
|
(1R,4aS)-Decahydro-1-[(R)-5-hydroxy-3-methylpentyl]-2,5,5,8aβ-tetramethyl-2α,3β-naphthalenediol
|
|
52329-57-4
|
|
|
(1R,4aα,βS)-Decahydro-2α-hydroxy-β,2,5,5,8aβ-pentamethyl-1-naphthalenepentanoic acid methyl ester
|
|
10267-25-1
|
|
|
Ras-dependent extracellular signal-regulated kinase kinase stimulator
|
|
|
|
|
(2R,11aS)-2,3-Dihydro-8-benzoyloxy-2β-hydroxy-7-methoxy-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione
|
|
|
|
|
(1R,8aα,9S)-6β-[(Dimethylamino)methyl]-1,5a,6,7,8,8a-hexahydro-5aα-methyl-9-isopropyl-1,4α-methano-2H-cyclopent[d]oxepine-2,5(4H)-dione
|
|
4684-24-6
|
|
|
(1R)-7-[(aS)-4,5-Dimethoxy-2-methyl-1-naphtyl]-1,2,3,4-tetrahydro-1β,2,3α-trimethylisoquinolin-8-ol
|
|
|
|
|
(5R,8aS)-3,3-Dimethyl-5-phenyl-1,2,3,5,6,8a-hexahydroindolizin-7(8H)-one
|
|
|
|
|
(2R,11aS)-2,3-Dihydro-2β-hydroxy-10-methyl-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione
|
|
|
|
|
(11R,11aS)-8,11-Dihydroxy-1,2,3,10,11,11aβ-hexahydro-7-methoxy-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one
|
|
|
|
|
(R)-Aseanostatin P5
|
|
|
|
|
(1R,9aR)-Octahydro-2H-quinolizine-1α-carboxylic acid
|
|
574-99-2
|
|
|
(1R,7aR)-Octahydro-1-[(S)-1-isothiocyanato-2-methylpropyl]-3aα-methyl-7-methylene-1H-indene
|
|
53822-97-2
|
|
|
[1R,9aR,(-)]-Octahydro-2H-quinolizine-1-methanol acrylate
|
|
60537-74-8
|
|
|
(1R,7aβ,αR)-Octahydro-α,3aβ,5α-trimethyl-6,8-dioxo-1α,4α-methano-1H-indene-1-acetic acid
|
|
34167-05-0
|
|
|
(1R,7aR)-Octahydro-1-[(S)-1-isocyano-2-methylpropyl]-3aα-methyl-7-methylene-1H-indene
|
|
53822-96-1
|
|
|
[(1R,1α,4α)-Bicyclo[2.2.1]heptan-2α-yl] isothiocyanate
|
|
|
|
|
(R)-Bicyclo[2.2.2]octan-2-ol
|
|
37165-30-3
|
|
|
(1R,6β)-Bicyclo[4.1.0]heptan-2β-ol
|
|
|
|
|
[(2R)-Bicyclo[2.2.1]heptan-2-yl]methanol
|
|
|
|
|
RAS, (CYSTEINE-VALINE-LEUCINE-LEUCINE) HUMAN
|
|
|
C20H38N4O5S
|
|
rasD protein
|
|
|
|
|
rasfadin
|
|
|
|
|
(1R,4aS,7E,9R,11aR)-4-[(1R,2R)-1,2-Diacetoxy-4-methyl-3-pentenyl]-1,4a,5,6,9,10,11,11a-octahydro-7-methyl-11-methylenecyclonona[c]pyran-1,9-diol diacetate
|
|
64504-52-5
|
|
|
(3R,8AR)-3-PHENYL-HEXAHYDRO-OXAZOLO[3,2-A]PYRIDIN-5-ONE
|
|
|
C13H15NO2
|
|
(5R,8AR)-3-PHENYLHEXAHYDRO-5H-[1,3]OXAZOLO[3,2-A]PYRIDINE-5-CARBONITRILE
|
|
|
|
|
(3R,3aS,6E,9S,10E,11aS)-2,3,3a,4,5,8,9,11a-Octahydro-9-hydroxy-3,6,10-trimethylcyclodeca[b]furan-2-one
|
|
31560-72-2
|
|
|
(-)-R-Arotinolol
|
|
92075-58-6
|
|
|
RAS-GAP PEPTIDE
|
|
|
|
|
ras-GAP-SH3-domain-binding protein, G3BP
|
|
|
|
|
(3R,8aS)-3-(3-fluorobenzyl)octahydropyrrolo[1,2-a]pyrazine
|
|
|
C14H19FN2
|
|
(7R,8aS)-7-fluorooctahydropyrrolo[1,2-a]pyrazine
|
|
|
C7H13FN2
|
|
(3R,8aS)-3-(2-fluorobenzyl)octahydropyrrolo[1,2-a]pyrazine
|
|
|
C14H19FN2
|
|
(R)-Bifonazole
|
|
91487-85-3
|
|
|
rasfonin
|
|
|
|
|
Rar1 protein
|
|
|
|
|
(7R,7aR,14R,14aS)-Dodecahydro-7,14-methano-4H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine-4-one
|
|
486-88-4
|
|
|
(3R,5'aS)-5-(3-Furanyl)-3',5',5'aβ,7',8',8'aβ-hexahydro-7'β-methylspiro[furan-3(2H),6'-[6H]naphtho[1,8-bc]furan]-2,2'(4'H)-dione
|
|
66322-19-8
|
|
|
(3R,3aR,6R,6aR)-3,6-Bis(acetyloxy)-2,3,3a,5,6,6a-hexahydrothieno[3,2-b]thiophene 1,4-dioxide
|
|
|
|
|
(2R,4aR,5R,7aR)-2-(1,1-Difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-heptanoic acid
|
(2R,4AR,5R,7AR)-2-(1,1-二氟戊基)-2-羟基-6-氧代-3,4,4A,5,7,7A-六氢环戊并[B]吡喃-5-庚酸
|
333963-40-9
|
C20H32F2O5
|
|
(1R,3AR,4R,6AR)-3A,6A-DIMETHYLHEXAHYDRO-1H-1,4-METHANOCYCLOPENTA[C]FURAN-1-CARBOXYLIC ACID
|
|
|
|
|
(2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol
|
(2R)-1-{4-[(1AR,6R,10BS)-1,1-二氟-1,1A,6,10B-四氢二苯并[A,E]环丙并[C]环庚烯-6-基]哌嗪-1-基}-3-(喹啉-5-基氧基)丙-2-醇
|
167354-41-8
|
C32H31F2N3O2
|
|
(7R,7AR,14R)-DODECAHYDRO-7,14-METHANO-DIPYRIDO[1,2-A:1',2'-E][1,5]DIAZOCINE
|
|
|
C15H24N2
|
|
(1R,3aR,6R,9E,12aS)-3,3a,6,7,8,11,12,12a-Octahydro-3a,6,10-trimethyl-1-isopropylcyclopentacycloundecene-2,4(1H,5H)-dione
|
|
|
|
|
(11R,11aS)-2,3,5,6,7,8-Hexahydro-3'-methoxy-4',9-dimethylspiro[1H-cyclopenta[b]pyrrolo[1,2-a]azepine-11(10H),2'(5'H)-furan]-5',10-dione
|
|
|
|
|
(3R,3aR,4R,6E,9R,10E,11aR)-4,9-Bisacetoxy-3a,4,5,8,9,11a-hexahydro-3,6,10-trimethylcyclodeca[b]furan-2(3H)-one
|
|
56192-71-3
|
|
|
(1R,7aS)-Hexahydro-1H-pyrrolizine-1α-methanol acetate
|
|
|
|